A Compendium of Clinical Research and Practice


Subscribe Current Issue Archives Continuing Education Submit an Article Contact Us
Search Articles:
Wounds Home
Current Issue
Archives
Search Articles
Subscribe to Wounds
Industry News
New Products
Classifieds
Continuing Education
Supplements
Enewsletters
Editorial Board
Contact Us
Author Instructions
Rapid Review
About Us

Bioengineered skin equivalent
Negative pressure wound therapy
Acellular dermal matrix
Diabetic neuropathy
Silver dressings
Enzymatic debridement

Autolytic debridement
Wound necrosis
Surgical debridement
Mechanical debridement
Wound fibroblasts
Delayed wound healing
Impaired wound healing
Compression stockings
Diabetic foot wounds
Pressure dressing
Diabetic Foot Ulcers
Evidence Corner:
Diabetic Foot Ulcers

- Laura Bolton, PhD



Laura Bolton, PhD
Dear Readers: Foot problems are the most frequent cause of hospitalization in diabetic patients. Peripheral neuropathy leads to loss of protective sensation, and unheeded trauma results in ulceration with a high potential for infection and amputation. Consistent offloading has reportedly healed up to 80 percent of diabetic foot ulcers within 10 weeks,1 but patient adherence to the offloading protocols is inconsistent, and the total contact casts, which assure adherence to achieve these sterling results, require skill to apply. Below are two recent additions to the continuing search for topical modalities to heal these difficult wounds, identifying one debridement modality with healing benefits. While the search for effective topical care continues, clinicians face the challenge of offloading pressure points on the plantar surface consistently and well. Without effective offloading, topical treatment makes small headway against repeated trauma of the patient’s weight on the affected foot surface.

Laura L. Bolton, PhD
Department Editor

Randomized Controlled Trial of Collagen/Oxidized Regenerated Cellulose Dressing

Reference: Veves A, Sheehan P, Pham HT, for the Promogran® Diabetic Foot Ulcer Study. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs. standard treatment in the management of diabetic foot ulcers. Arch Surg 2002;137:822–7.

Rationale: Primary dressings are needed that might afford healing benefits for diabetic foot ulcers better than the effects of standard primary dressing with moistened gauze.

Objective: This study compared the effect of a collagen/oxidized regenerated cellulose dressing (C/ORC) versus saline-moistened gauze primary dressings on complete wound closure of foot ulcers of diabetic patients being treated in university teaching hospitals and primary care centers.

Methods: After a baseline medical history, which included reporting ulcer duration, type and prior management, and patient activity level and ambulatory status, 138 patients were randomly assigned to each dressing group, receiving either saline-moistened gauze or C/ORC dressing. Offloading techniques were standardized to the accepted protocol within the center but varied between centers. Both dressings were changed when clinically required for a maximum period of 12 weeks. Healing efficacy, safety, and patient and physician preferences were recorded.

Results: There were no significant differences in safety and efficacy of the two dressings, with 90 percent of patients in both groups adhering to the protocol. Among the C/ORC-dressed ulcers, 37 percent healed after 12 weeks as compared to 28.3 percent of moist gauze-dressed ulcers
(p = 0.12). In the subset of ulcers with lower than six-month duration, 45 percent of the 95 C/ORC-dressed ulcers healed at 12 weeks, as compared to 33 percent of 89 moist gauze-dressed ulcers (p = 0.056). Both patients and physicians preferred the C/ORC dressings.

Conclusions: As a primary dressing on diabetic foot ulcers, the C/ORC dressing was comparable in safety and healing effects to saline-moistened gauze, though both patients and physicians preferred C/ORC.

Clinical perspective: In clinical studies of wound healing on diabetic patients with plantar ulcers, there can be wide variability in the wound response to different offloading techniques or patient adherence to these offloading regimens, as well as blood glucose control and peripheral circulation differences. These sources of variability can overshadow effects of primary wound dressings on wound outcomes, a fact that alerts clinicians to the value of quality, consistent offloading of the diabetic lower extremity.

Evidence Summary: Healing Effects of Diabetic Foot Debridement

Reference: Smith J. Debridement of diabetic foot ulcers (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software. (www.cochrane.org. Accessed April 25, 2003)

Rationale: Foot ulceration is believed to affect 15 percent of people with diabetes at some time during their lives. Debridement of necrotic tissue is necessary before a diabetic foot ulcer can heal.

Objective: This systematic Cochrane review of the literature explored effectiveness of debridement as a treatment for improving healing of diabetic foot ulcers.

Methods: All randomized controlled trials (RCTs) comparing effect of debridement modalities on either complete diabetic foot ulcer healing or rate of diabetic foot ulcer healing were included in the review, without language or publication status restrictions.

Results: The following five RCTs were found assessing effectiveness of debridement on diabetic foot ulcer healing: Pooled results from three RCTs suggest that autolytic debridement using hydrogels is significantly more effective than gauze or standard care in healing diabetic foot ulcers. Small trials on surgical or larval debridement showed no significant benefit to diabetic ulcer healing. No RCTs were found evaluating effects of other debridement methods, such as enzymes or polysaccharide beads, on diabetic foot ulcer healing.

Conclusions: The reviewer concludes that there is evidence that autolytic debridement using hydrogel increases the healing rate of diabetic foot ulcers.

Clinical perspective: Necrotic tissue removal has long been suspected to aid healing. Considerable research has measured debriding effects without examining healing efficacy.2 This Cochrane review is a rare summary of findings supporting necrotic tissue removal as an aid to healing, the real “bottom line” for patients with diabetic foot ulcers. Perhaps this summary will stimulate research into the relative benefits of those debriding modalities that, as yet, lack proof of healing efficacy for diabetic foot ulcers.

References:
1. Laing P. Diabetic foot ulcers. Amer J Surgery 1994;167 (Suppl 1A):31S–36S.
2. Bolton L, Fattu AJ. Topical agents and wound healing. Clin Dermatol 1994;12:95–120.


Wounds - ISSN: 1044-7946 - Volume 13 - Issue 6 - December 2001 - Pages: A19 - A20



Supplements:

Special Publication:
The following is a collection of publications from Healthpoint intended to facilitate expeditious, cost-effective wound care management. There will be nine publications total.

Related Links:
Symposium on Advanced Wound Care (SAWC)
The Buck Stops Here
Association of Advanced Wound Care
Ostomy/Wound Management
Podiatry Today
Vascular Disease Management
Wound Healing Society

Article Submission:
All submissions for consideration should be submitted online using the Rapid Review Web-Based Review System at www.rapidreview.com. Authors should scroll down to HMP Communications and click on Author.


© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd | Suite 100 | Malvern, PA 19355